HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Crawford Nomination Woes Grow With Coburn Hold, Hager Letter

This article was originally published in The Tan Sheet

Executive Summary

FDA Acting Commissioner Lester Crawford's bid for the permanent post has been cast further into doubt by a Republican joining the list of Senators threatening holds on his nomination

You may also be interested in...



FDA Did Not Seek Plan B “Minority Opinion,” Crawford Tells Subcommittee

FDA never asked for or received a memo from former Reproductive Health Drugs Advisory Committee member David Hager, MD, outlining a "minority opinion" on the possible Rx-to-OTC switch of Plan B, Commissioner Lester Crawford stated July 26

House Approps Subcommittee Slaps FDA On The Wrist For Crawford Absence

The House Appropriations/Agriculture Subcommittee voted May 17 to withhold 5% of the funds for FDA's central offices until Acting Commissioner Lester Crawford testifies before the committee on the President's FY 2006 budget request

Nonoxynol-9 Messages Conveyed By HHS Agencies Inconsistent – GAO Report

FDA will release three documents this year on the use of spermicidal lubricant nonoxynol-9 in condoms and vaginal contraceptives to protect against HIV transmission

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS127116

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel